Femi Ogunleye/LinkedIn
May 17, 2026, 17:35
Femi Ogunleye: New PhD Publication on Targeted Thrombolysis
Femi Ogunleye, Doctoral Researcher at Shenzen Institute of Advanced Technology University of Chinese academy of science, shared a post on LinkedIn:
“I am thrilled to announce our latest publication, as a part of my PhD work, titled Platelet-membrane-coated nanoparticles enable safe and targeted thrombolysis with preserved neurovascular integrity.”
Title: Platelet-membrane-coated nanoparticles enable safe and targeted thrombolysis with preserved neurovascular integrity
Authors: Ziying Feng, Ogunleye Femi Abiola, Guojun Huang, Tianfang Kang, Fan Xu, Ping Gong, Junlei Chang, Hong Pan, Yinzhong Ma
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 14:06Khalid Alfawaz: Signed Consent Doesn’t Always Mean Informed
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci